Darolutamide in nonmetastatic, castration-resistant prostate cancer

ARAMIS Investigators

Research output: Contribution to journal › Article › peer-review

496 Citations (Scopus)

3 Downloads (Pure)

496 Citations
1 Erratum

1 results

Filter

2022

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246)
Fizazi, K., Shore, N., Tammela, TL., Ulys, A., Vjaters, E., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Kuss, I., Kappeler, C., Snapir, A., Sarapohja, T. & Smith, MR., 1 Sept 2022, In: New England Journal of Medicine. 387, 9, p. 860-860 1 p.
Research output: Contribution to journal › Erratum › peer-review